Financial results - DRUG ZOO SRL

0.00
Financial Summary - Drug Zoo Srl
Unique identification code: 18514675
Registration number: J08/718/2006
Nace: 150
Sales - Ron
11.022
Net Profit - Ron
5.124
Employee
1
Open Account
The most important financial indicators for the company Drug Zoo Srl - Unique Identification Number 18514675: sales in 2023 was 11.022 euro, registering a net profit of 5.124 euro and having an average number of 1 employees. Firma isi desfasoara activitatea in domeniul Activitati in ferme mixte (cultura vegetala combinata cu cresterea animalelor) having the NACE code 150.

Sales, Profit, Employees, Debts, Capitals, Financial Results - Drug Zoo Srl

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Sales - EUR 40.931 42.468 50.688 56.521 73.703 65.343 34.751 17.963 44.232 11.022
Total Income - EUR 48.555 55.900 56.760 75.700 71.580 73.190 64.999 58.700 56.707 72.373
Total Expenses - EUR 62.587 46.564 40.559 50.484 67.675 54.380 49.075 55.783 54.091 66.742
Gross Profit/Loss - EUR -14.032 9.336 16.201 25.216 3.905 18.810 15.923 2.918 2.616 5.631
Net Profit/Loss - EUR -15.268 7.916 15.187 22.049 3.514 18.221 14.894 1.543 1.998 5.124
Employees 2 3 3 3 2 1 1 0 1 1
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity. The data show the company's evolution during this period, highlighting any increases or potential decreases recorded. In the last year of activity, the sales decreased by -75.0%, from 44.232 euro in the year 2022, to 11.022 euro in 2023. The Net Profit increased by 3.132 euro, from 1.998 euro in 2022, to 5.124 in the last year.
See Company Data

Check the financial reports for the company - Drug Zoo Srl

Rating financiar

Rating financiar -
Drug Zoo Srl

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Check Financial Rating
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Drug Zoo Srl - CUI 18514675

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Fixed Assets 59.714 56.307 85.572 66.673 65.605 77.302 89.400 161.670 124.559 140.022
Current Assets 89.677 91.996 96.110 138.269 169.653 190.720 180.128 109.713 128.224 133.507
Inventories 54.563 51.808 32.140 43.445 33.319 35.792 32.056 31.918 30.617 41.578
Receivables 34.792 39.601 50.985 85.647 129.264 147.396 143.098 77.710 91.612 82.990
Cash 322 588 12.984 9.176 7.070 7.533 4.974 84 5.995 8.939
Shareholders Funds -19.528 -11.775 3.532 -16.346 -12.532 5.932 20.714 21.797 23.863 28.915
Social Capital 6.247 6.299 6.235 6.129 6.017 5.900 5.789 5.660 5.678 5.661
Debts 249.227 234.357 254.248 244.015 259.487 250.833 226.518 173.487 160.668 164.306
Income in Advance 0 0 0 0 0 0 0 0 0 0
Exchange rate - RON 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445 4.4821
Main CAEN "150 - 150"
CAEN Financial Year 150
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 133.507 euro in 2023 which includes Inventories of 41.578 euro, Receivables of 82.990 euro and cash availability of 8.939 euro.
The company's Equity was valued at 28.915 euro, while total Liabilities amounted to 164.306 euro. Equity increased by 5.124 euro, from 23.863 euro in 2022, to 28.915 in 2023.
Monitors the Company

Activate a subscription with unlimited access and get contact details for any company.

Subscriptions Financial Reports

You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.

Recurring - monthly payment

Pay

25,21 EUR / month
NELIMITAT

Reports that can be accessed based on the subscription:

  • ✔ Financial Rating
  • ✔ Payment Limits
  • ✔ Outstanding Debts
  • ✔ Probability of Insolvency
Subscription cost is per user. You can pay simultaneously up to 10 users.
RisCo Subscriptions offer the greatest flexibility in choosing the best services according to the needs of each user. These are structured into categories based on the type of service desired, as well as on different service contract periods: monthly, semi-annually, and annually. Check out the subscription offer for the best choices!
See Subscriptions

Similar services useful for checking companies and business development.

Contacts Firms

Get the contact details for any company and get in touch with it.
Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.